| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...859772B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0059772 |
| P932 | PMC publication ID | 3606107 |
| P698 | PubMed publication ID | 23533649 |
| P5875 | ResearchGate publication ID | 236085182 |
| P2093 | author name string | Hui Liu | |
| Feifei Chen | |||
| Chen Li | |||
| Cuipeng Zhang | |||
| Jin Bai | |||
| Junnian Zheng | |||
| Pengjin Mei | |||
| Zhenqiang Pan | |||
| P2860 | cites work | Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest | Q22008677 |
| BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer | Q24273430 | ||
| Diversity and specialization of mammalian SWI/SNF complexes | Q24322918 | ||
| BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines | Q28138156 | ||
| Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up | Q28306437 | ||
| A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes | Q28589309 | ||
| Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma | Q33578231 | ||
| The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner | Q34170839 | ||
| When the SWI/SNF complex remodels...the cell cycle | Q34290272 | ||
| Chromatin remodelling during development | Q34698385 | ||
| [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue] | Q68175965 | ||
| Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas | Q77222548 | ||
| Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes | Q79266982 | ||
| Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness. | Q34992490 | ||
| Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene | Q35667390 | ||
| Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression | Q36354441 | ||
| Matrix metalloproteinases and tumor metastasis | Q36471104 | ||
| Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control | Q37085986 | ||
| BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer. | Q37379574 | ||
| The SWI/SNF complex and cancer | Q37398568 | ||
| Breast cancer statistics, 2011 | Q37942073 | ||
| Diverse functions of ATP-dependent chromatin remodeling complexes in development and cancer | Q37970954 | ||
| MLK3 Regulates Paxillin Phosphorylation in Chemokine-Mediated Breast Cancer Cell Migration and Invasion to Drive Metastasis | Q39330842 | ||
| BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro | Q39391018 | ||
| Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas | Q39469747 | ||
| RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration | Q39472960 | ||
| BRG1 expression is increased in human cutaneous melanoma | Q39701593 | ||
| The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. | Q39850197 | ||
| Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers | Q40213912 | ||
| Role for BRG1 in cell cycle control and tumor suppression | Q40376914 | ||
| Chromatin structure and DNA damage repair | Q41189289 | ||
| Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells. | Q42276895 | ||
| BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours. | Q42488147 | ||
| Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. | Q47233081 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | e59772 | |
| P577 | publication date | 2013-03-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | BRG1 is a prognostic marker and potential therapeutic target in human breast cancer | |
| P478 | volume | 8 |
| Q38220523 | A rationale to target the SWI/SNF complex for cancer therapy |
| Q90380751 | AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy induction |
| Q35647469 | Approaches to identifying synthetic lethal interactions in cancer. |
| Q39010963 | BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions in vivo |
| Q64935151 | BRG1 is a prognostic indicator and a potential therapeutic target for prostate cancer. |
| Q33898452 | BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness |
| Q38784675 | BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways |
| Q38379487 | Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation |
| Q37530496 | Brahma-related gene 1 induces apoptosis in a p53-dependent manner in human rheumatoid fibroblast-like synoviocyte MH7A |
| Q57754503 | Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis |
| Q61800386 | CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary |
| Q38261746 | Chromatin remodeler mutations in human cancers: epigenetic implications |
| Q30353348 | Deletion of Arid1a in Reproductive Tract Mesenchymal Cells Reduces Fertility in Female Mice. |
| Q34260197 | Flavonoids from each of the six structural groups reactivate BRM, a possible cofactor for the anticancer effects of flavonoids |
| Q42369328 | Functional roles of CTCF in breast cancer |
| Q49301622 | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. |
| Q89605002 | Histone Modifying Enzymes and Chromatin Modifiers in Glioma Pathobiology and Therapy Responses |
| Q36166929 | Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study |
| Q37079565 | Identification of Novel Regulators of the JAK/STAT Signaling Pathway that Control Border Cell Migration in the Drosophila Ovary. |
| Q38259533 | Impact of proteolytic enzymes in colorectal cancer development and progression |
| Q64120089 | LCE: an open web portal to explore gene expression and clinical associations in lung cancer |
| Q37736010 | Mammalian SWI/SNF Enzymes and the Epigenetics of Tumor Cell Metabolic Reprogramming |
| Q37636601 | Mechanism of BRG1 silencing in primary cancers |
| Q37109724 | MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway |
| Q57287731 | MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1 |
| Q92381563 | Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle |
| Q88667939 | Nuclear organization mediates cancer-compromised genetic and epigenetic control |
| Q37435978 | Nuclear p27 expression confers a favorable outcome for nasopharyngeal carcinoma patients |
| Q50045806 | Oridonin inhibits proliferation of Jurkat cells via the down-regulation of Brg1 |
| Q38768154 | SMARCAD1 knockdown uncovers its role in breast cancer cell migration, invasion, and metastasis |
| Q37317194 | Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells |
| Q50640303 | The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer |
| Q42008283 | The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation |
| Q30659086 | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation |
| Q92025302 | The SWI/SNF complex in cancer - biology, biomarkers and therapy |
| Q37699177 | The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A. |
| Q90255136 | The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review |
| Q47095944 | ndmaSNF: cancer subtype discovery based on integrative framework assisted by network diffusion model |
Search more.